Mice Model Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2032)

Mice Model Market Insights

According to the report published by Market Research Store, the global Mice Model Market size was valued at USD 1,217.90 Million in 2023 and is predicted to reach USD 2,475.50 Million by the end of 2032. The market is expected to grow with a CAGR of 8.20% during the forecast period. The report analyzes the global Mice Model Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Mice Model Market industry.

Global Mice Model Market: Overview

The mouse is a mammal with genetic tools that are sophisticated and their genetic resources are very significant, hence it is used as a popular model system. In order to explore the human pathophysiology and the progression of the diseases, the mice are the best model for this purpose. New models are being developed in which the human cells and tissues are being reconstituted. As most of their genes are shared with humans new opportunities are getting opened up for the genetic testing.

Global Mice Model Market: Growth Factors

The important factors that are contributing to the market growth are the ongoing developments that are made in the mouse models and the increasing demand for the medicines that are personalized. The increase in the research and development activities in the pharmaceutical sector accounts for the growth of the mice model market in the coming years.

 Additionally, the mice models are used for the research activities of the diseases that are rare hence increasing its demand in the global market. There has been an increase in the monoclonal antibody production which is contributing to the overall development of the global mice model market.

Mice Model Market: Report Scope

Global Mice Model Market: Segmentation

The global mice model market is segmented based on type, technology, application, and service, addressing diverse research needs in pharmaceuticals, biotechnology, and academic institutions.

By type, the market includes genetically engineered mice, hybrid/congenic mice, spontaneous mutant mice, inbred mice, conditioned/surgically modified mice, and outbred mice. These categories cater to specific research requirements, ranging from genetic disorder studies to pharmacological testing.

Based on technology, the market is classified into microinjection, nuclear transfer, genetically modified sperm-mediated gene transfer, electroporation of DNA & liposome-mediated DNA transfer, CRISPR, embryonic stem cell injection, virus/vector-mediated gene transfer, biolistics, and TALENs & ZFN. Advancements in these technologies are driving innovation in genetic engineering and biomedical research.

The mice model is widely used in applications such as immunology and inflammation studies, cardiovascular studies, rare diseases, toxicology, oncology, diabetes, central nervous system studies, renal disorders, hematopoiesis, and others. The growing prevalence of chronic diseases and the need for effective therapeutic solutions are fueling demand across these research areas.

In terms of services, the market is divided into cryopreservation, rederivation, model in-licensing, surgical services, in vivo pharmacology services, breeding services, quarantine, genetic testing, and line rescue. These services support research institutions by providing specialized mice models, maintaining genetic integrity, and ensuring compliance with regulatory standards.

With the increasing focus on drug development, disease modeling, and genetic research, the global mice model market is expected to witness significant growth in the coming years.

Global Mice Model Market: Regional Analysis

Region-wise, the global mice model market is diversified into regions such as North America, Asia-Pacific, Europe, and Rest of the World. The region that dominates the global mice model market is the North America. This dominance is going to continue in the coming years too owing to the presence of the large pharmaceutical sectors in the North American region and also there are tremendous research and development activities that are done in this region.

Europe holds the second leading position in the global market. The increasing demand for the knockout and transgenic mice models attributes to the mice model market growth in the Asia-Pacific region. The countries that contribute a major share in the market growth are China, Malaysia, India, and Singapore.

Global Mice Model Market: Competitive Players 

The global mice model market is highly competitive, driven by increasing demand for genetically modified mice in biomedical research, drug development, and disease modeling. Leading companies focus on advancements in gene-editing technologies, breeding techniques, and collaborations with pharmaceutical and research institutions to enhance their market presence. The rise in preclinical studies, personalized medicine, and the need for efficient in vivo testing contribute to market expansion. Additionally, regulatory compliance, ethical considerations, and technological innovations in CRISPR and transgenic models shape the competitive landscape, encouraging players to invest in R&D and expand their service offerings.

The major market players in the mice model market include:

• Horizon Discovery Group Plc.
• ENVIGO
• Ingenious Targeting Laboratory
• Harbour Antibodies Bv
• The Jackson Laboratory
• Genoway
• Laboratory Corporation of America Holdings
• Trans Genic, Inc.
• Janvier Labs
• Taconic Biosciences, Inc.
• Charles River Laboratories International, Inc.

Mice Model Market by Segments

By Type 

• Genetically Engineered Mice 
• Hybrid/Congenic Mice 
• Spontaneous Mutant Mice 
• Inbred Mice 
• Conditioned/Surgically Modified Mice 
• Outbred Mice 

By Technology 

• Microinjection 
• Nuclear Transfer 
• Genetically Modified Sperm-Mediated Gene Transfer 
• Electroporation Of DNA & Liposome-Mediated DNA 
• CRISPR 
• Embryonic Stem Cell Injection 
• Virus/Vector-Mediated Gene Transfer
• Biolistics
• TALENs & ZFN 

By Application 

• Immunology and Inflammation Studies
• Cardiovascular Studies
• Rare Diseases 
• Toxicology
• Oncology Studies
• Diabetes Studies
• Central Nervous System Studies 
• Renal Disorders 
• Hematopoiesis

By Service 

• Cryopreservation 
• Rederivation Model In Licensing 
• Surgical 
• In Vivo Pharmacology Services
• Breeding Services 
• Quarantine 
• Genetic Testing 
• Line Rescue

Mice Model Market by Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.

Frequently Asked Questions